Reported Earnings • May 16
Full year 2026 earnings released: EPS: ₹0.76 (vs ₹0.68 in FY 2025) Full year 2026 results: EPS: ₹0.76 (up from ₹0.68 in FY 2025). Revenue: ₹163.6m (down 50% from FY 2025). Net income: ₹38.2m (up 29% from FY 2025). Profit margin: 23% (up from 9.1% in FY 2025). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • May 11
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹18.60, the stock trades at a trailing P/E ratio of 27x. Average trailing P/E is 21x in the Consumer Finance industry in India. Total returns to shareholders of 4.7% over the past three years. Announcement • May 04
Fervent Synergies Limited to Report Fiscal Year 2026 Results on May 14, 2026 Fervent Synergies Limited announced that they will report fiscal year 2026 results on May 14, 2026 Valuation Update With 7 Day Price Move • Mar 20
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹19.00, the stock trades at a trailing P/E ratio of 27.6x. Average trailing P/E is 17x in the Consumer Finance industry in India. Total returns to shareholders of 18% over the past three years. New Risk • Mar 02
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹945.0m (US$10.3m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹945.0m market cap, or US$10.3m). Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Revenue is less than US$5m (₹165m revenue, or US$1.8m). Valuation Update With 7 Day Price Move • Mar 02
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹16.82, the stock trades at a trailing P/E ratio of 24.4x. Average trailing P/E is 19x in the Consumer Finance industry in India. Total loss to shareholders of 12% over the past three years. New Risk • Feb 06
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.1% average weekly change). Minor Risks Revenue is less than US$5m (₹165m revenue, or US$1.8m). Market cap is less than US$100m (₹1.01b market cap, or US$11.1m). Reported Earnings • Feb 06
Third quarter 2026 earnings released: EPS: ₹0.43 (vs ₹0.54 in 3Q 2025) Third quarter 2026 results: EPS: ₹0.43 (down from ₹0.54 in 3Q 2025). Revenue: ₹97.8m (down 63% from 3Q 2025). Net income: ₹21.4m (down 9.1% from 3Q 2025). Profit margin: 22% (up from 8.9% in 3Q 2025). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 6% per year. Announcement • Jan 27
Fervent Synergies Limited to Report Q3, 2026 Results on Feb 05, 2026 Fervent Synergies Limited announced that they will report Q3, 2026 results on Feb 05, 2026 New Risk • Jan 20
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹901.0m (US$9.90m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (41% accrual ratio). Market cap is less than US$10m (₹901.0m market cap, or US$9.90m). Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Revenue is less than US$5m (₹331m revenue, or US$3.6m). Valuation Update With 7 Day Price Move • Dec 02
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₹18.88, the stock trades at a trailing P/E ratio of 25.8x. Average trailing P/E is 25x in the Consumer Finance industry in India. Total returns to shareholders of 30% over the past three years. Reported Earnings • Nov 08
Second quarter 2026 earnings released: EPS: ₹0.09 (vs ₹0.014 in 2Q 2025) Second quarter 2026 results: EPS: ₹0.09 (up from ₹0.014 in 2Q 2025). Revenue: ₹6.84m (up 76% from 2Q 2025). Net income: ₹4.34m (up ₹3.96m from 2Q 2025). Profit margin: 63% (up from 9.6% in 2Q 2025). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings. Announcement • Oct 29
Fervent Synergies Limited to Report Q2, 2026 Results on Nov 06, 2025 Fervent Synergies Limited announced that they will report Q2, 2026 results on Nov 06, 2025 Reported Earnings • Jul 25
First quarter 2026 earnings released: EPS: ₹0.08 (vs ₹0.02 in 1Q 2025) First quarter 2026 results: EPS: ₹0.08 (up from ₹0.02 in 1Q 2025). Revenue: ₹6.83m (up 100% from 1Q 2025). Net income: ₹3.83m (up 433% from 1Q 2025). Profit margin: 56% (up from 21% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has increased by 26% per year, which means it is well ahead of earnings. Announcement • Jul 24
Fervent Synergies Limited, Annual General Meeting, Sep 18, 2025 Fervent Synergies Limited, Annual General Meeting, Sep 18, 2025, at 11:00 Indian Standard Time. Announcement • Jul 16
Fervent Synergies Limited to Report Q1, 2026 Results on Jul 24, 2025 Fervent Synergies Limited announced that they will report Q1, 2026 results on Jul 24, 2025 Valuation Update With 7 Day Price Move • Jul 11
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to ₹24.48, the stock trades at a trailing P/E ratio of 41.4x. Average trailing P/E is 29x in the Consumer Finance industry in India. Total returns to shareholders of 82% over the past three years. Reported Earnings • May 23
Full year 2025 earnings released: EPS: ₹0.68 (vs ₹4.28 loss in FY 2024) Full year 2025 results: EPS: ₹0.68 (up from ₹4.28 loss in FY 2024). Revenue: ₹324.6m (up 34% from FY 2024). Net income: ₹29.5m (up ₹158.0m from FY 2024). Profit margin: 9.1% (up from net loss in FY 2024). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance. Announcement • May 13
Fervent Synergies Limited to Report Fiscal Year 2025 Results on May 22, 2025 Fervent Synergies Limited announced that they will report fiscal year 2025 results on May 22, 2025 New Risk • Jan 24
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₹51m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹51m free cash flow). Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 87% per year over the past 5 years. Shareholders have been substantially diluted in the past year (46% increase in shares outstanding). Minor Risks Revenue is less than US$5m (₹419m revenue, or US$4.9m). Market cap is less than US$100m (₹1.15b market cap, or US$13.3m). Reported Earnings • Jan 24
Third quarter 2025 earnings released: EPS: ₹0.54 (vs ₹0.12 in 3Q 2024) Third quarter 2025 results: EPS: ₹0.54 (up from ₹0.12 in 3Q 2024). Revenue: ₹263.3m (up 198% from 3Q 2024). Net income: ₹23.5m (up ₹19.8m from 3Q 2024). Profit margin: 8.9% (up from 4.2% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 138 percentage points per year, which is a significant difference in performance. New Risk • Jan 16
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 46% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10.0% average weekly change). Earnings have declined by 91% per year over the past 5 years. Shareholders have been substantially diluted in the past year (46% increase in shares outstanding). Minor Risks Revenue is less than US$5m (₹244m revenue, or US$2.8m). Market cap is less than US$100m (₹872.8m market cap, or US$10.1m). Announcement • Jan 11
Fervent Synergies Limited to Report Q3, 2025 Results on Jan 23, 2025 Fervent Synergies Limited announced that they will report Q3, 2025 results on Jan 23, 2025 New Risk • Jan 03
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 46% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 91% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (46% increase in shares outstanding). Revenue is less than US$5m (₹244m revenue, or US$2.8m). Market cap is less than US$100m (₹938.9m market cap, or US$11.0m). Reported Earnings • Oct 25
Second quarter 2025 earnings released: EPS: ₹0.01 (vs ₹0.03 in 2Q 2024) Second quarter 2025 results: EPS: ₹0.01 (down from ₹0.03 in 2Q 2024). Revenue: ₹3.89m (up 23% from 2Q 2024). Net income: ₹374.0k (down 60% from 2Q 2024). Profit margin: 9.6% (down from 30% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 137 percentage points per year, which is a significant difference in performance. Announcement • Oct 17
Fervent Synergies Limited to Report Q2, 2025 Results on Oct 24, 2024 Fervent Synergies Limited announced that they will report Q2, 2025 results on Oct 24, 2024 New Risk • Sep 11
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.5% average weekly change). Earnings have declined by 92% per year over the past 5 years. Market cap is less than US$10m (₹586.8m market cap, or US$6.99m). Minor Risk Revenue is less than US$5m (₹243m revenue, or US$2.9m). Reported Earnings • Aug 09
First quarter 2025 earnings released: EPS: ₹0.02 (vs ₹0.03 in 1Q 2024) First quarter 2025 results: EPS: ₹0.02 (down from ₹0.03 in 1Q 2024). Revenue: ₹3.41m (up 8.3% from 1Q 2024). Net income: ₹718.0k (down 28% from 1Q 2024). Profit margin: 21% (down from 32% in 1Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 159 percentage points per year, which is a significant difference in performance. New Risk • Aug 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 86% per year over the past 5 years. Market cap is less than US$10m (₹615.6m market cap, or US$7.33m). Minor Risks Share price has been volatile over the past 3 months (9.2% average weekly change). Revenue is less than US$5m (₹243m revenue, or US$2.9m). Announcement • Aug 02
Fervent Synergies Limited announced that it has received INR 50 million in funding from Blue Berry Securities Pvt Ltd and other investors On August 1, 2024, Fervent Synergies Limited closed the transaction. Announcement • Jul 29
Fervent Synergies Limited to Report Q1, 2025 Results on Aug 08, 2024 Fervent Synergies Limited announced that they will report Q1, 2025 results on Aug 08, 2024 Announcement • May 31
Fervent Synergies Limited, Annual General Meeting, Jul 11, 2024 Fervent Synergies Limited, Annual General Meeting, Jul 11, 2024, at 11:00 Indian Standard Time. Reported Earnings • May 10
Full year 2024 earnings released: ₹4.28 loss per share (vs ₹0.077 profit in FY 2023) Full year 2024 results: ₹4.28 loss per share (down from ₹0.077 profit in FY 2023). Revenue: ₹243.1m (up 425% from FY 2023). Net loss: ₹128.4m (down ₹130.7m from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 139 percentage points per year, which is a significant difference in performance. Announcement • Mar 15
Fervent Synergies Limited Appoints Nehal Bharat Mehta as Company Secretary and Compliance Officer The board of directors of Fervent Synergies Limited at its meeting held on 15 March 2024, approved the Appointment of Ms. Nehal Bharat Mehta (A68104) as Company Secretary and Compliance Officer of the company with immediate effect. Ms. Nehal Bharat Mehta (A-68104) is a Qualified Company Secretary and an Associate member of The Institute of Company Secretaries of India (ICSI), and a Commerce Graduate from Mumbai University. Ms. Nehal Bharat Mehta has a diverse professional background with expertise in the field of Secretarial, Legal etc. She has worked on various assignment related to compliance and corporate secretarial functions including Board processes under the Companies Act and the SEBI Regulations. Announcement • Feb 05
Fervent Synergies Limited Announces Resignation of Pooja Sanghavi as Company Secretary / Compliance Officer Fervent Synergies Limited announced that Ms. Pooja Sanghavi, Company Secretary of the Company has tendered her resignation from the post of Company Secretary of the Company with effect from the close of working hours of 03rd February 2024. Consequent to her resignation, Ms. Pooja Sanghavi also ceases to be Compliance Officer of the Company. Reported Earnings • Jan 19
Third quarter 2024 earnings released Third quarter 2024 results: Revenue: ₹88.3m (up 170% from 3Q 2023). Net income: ₹3.71m (up 173% from 3Q 2023). Profit margin: 4.2% (in line with 3Q 2023). Reported Earnings • Nov 04
First half 2024 earnings released: EPS: ₹0.06 (vs ₹0.04 in 1H 2023) First half 2024 results: EPS: ₹0.06 (up from ₹0.04 in 1H 2023). Revenue: ₹6.30m (up 35% from 1H 2023). Net income: ₹1.94m (up 110% from 1H 2023). Profit margin: 31% (up from 20% in 1H 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Oct 26
Fervent Synergies Limited to Report Q2, 2024 Results on Nov 02, 2023 Fervent Synergies Limited announced that they will report Q2, 2024 results on Nov 02, 2023 New Risk • Oct 06
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.0% average weekly change). Earnings have declined by 55% per year over the past 5 years. Revenue is less than US$1m (₹47m revenue, or US$566k). Market cap is less than US$10m (₹628.5m market cap, or US$7.56m). Announcement • Aug 04
Fervent Synergies Limited, Annual General Meeting, Sep 28, 2023 Fervent Synergies Limited, Annual General Meeting, Sep 28, 2023, at 11:00 Indian Standard Time. Reported Earnings • Aug 04
First quarter 2024 earnings released: EPS: ₹0.03 (vs ₹0.02 in 1Q 2023) First quarter 2024 results: EPS: ₹0.03 (up from ₹0.02 in 1Q 2023). Revenue: ₹3.15m (up 34% from 1Q 2023). Net income: ₹1.00m (up 117% from 1Q 2023). Profit margin: 32% (up from 20% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 17% per year, which means it is well ahead of earnings. Announcement • Jul 18
Fervent Synergies Limited to Report Q1, 2024 Results on Aug 03, 2023 Fervent Synergies Limited announced that they will report Q1, 2024 results on Aug 03, 2023 Reported Earnings • May 20
Full year 2023 earnings released: EPS: ₹0.08 (vs ₹0.079 loss in FY 2022) Full year 2023 results: EPS: ₹0.08 (up from ₹0.079 loss in FY 2022). Revenue: ₹46.3m (up ₹39.3m from FY 2022). Net income: ₹2.30m (up ₹4.68m from FY 2022). Profit margin: 5.0% (up from net loss in FY 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. Reported Earnings • Feb 05
Third quarter 2023 earnings released: EPS: ₹0.05 (vs ₹0.01 loss in 3Q 2022) Third quarter 2023 results: EPS: ₹0.05 (up from ₹0.01 loss in 3Q 2022). Revenue: ₹32.7m (up ₹30.5m from 3Q 2022). Net income: ₹1.36m (up ₹1.63m from 3Q 2022). Profit margin: 4.2% (up from net loss in 3Q 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 79 percentage points per year, which is a significant difference in performance. Announcement • Jan 18
Fervent Synergies Limited to Report Q3, 2023 Results on Feb 02, 2023 Fervent Synergies Limited announced that they will report Q3, 2023 results on Feb 02, 2023 Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 5 highly experienced directors. Independent Non-Executive Director Falguni Mehta was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 21
Second quarter 2023 earnings released: EPS: ₹0.02 (vs ₹0.01 in 2Q 2022) Second quarter 2023 results: EPS: ₹0.02 (up from ₹0.01 in 2Q 2022). Net income: ₹459.0k (up 83% from 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance. Announcement • Oct 13
Fervent Synergies Limited to Report Q2, 2023 Results on Oct 20, 2022 Fervent Synergies Limited announced that they will report Q2, 2023 results on Oct 20, 2022 Reported Earnings • Aug 05
First quarter 2023 earnings released First quarter 2023 results: EPS: ₹0.02. Net income: ₹461.0k (up 284% from 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 93 percentage points per year, which is a significant difference in performance. Announcement • Aug 05
Fervent Synergies Limited, Annual General Meeting, Sep 22, 2022 Fervent Synergies Limited, Annual General Meeting, Sep 22, 2022. Announcement • Jul 28
Fervent Synergies Limited to Report Q1, 2023 Results on Aug 04, 2022 Fervent Synergies Limited announced that they will report Q1, 2023 results on Aug 04, 2022 Reported Earnings • May 15
Full year 2022 earnings released: ₹0.08 loss per share (vs ₹0.058 profit in FY 2021) Full year 2022 results: ₹0.08 loss per share (down from ₹0.058 profit in FY 2021). Net loss: ₹2.38m (down 236% from profit in FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 88 percentage points per year, which is a significant difference in performance. Announcement • May 07
Fervent Synergies Limited to Report Fiscal Year 2022 Results on May 12, 2022 Fervent Synergies Limited announced that they will report fiscal year 2022 results on May 12, 2022 Announcement • Apr 27
Fervent Pharmaceuticals Commences Virtual at Home Phase 2 Clinical Trial of a Peri- and Post-Menopausal Therapy for Treating Hot Flashes and Night Sweats Fervent Pharmaceuticals announced that it has commenced its virtual clinical study to evaluate the effectiveness of its novel product for the treatment of the symptoms of moderate to severe hot flashes, night sweats and nighttime awakenings due to hot flashes. This product is intended to be available, if approved by the FDA, for patients without the need for a prescription. This type of remote study is one of the first of its kind authorized by the FDA. Patients in the study will participate remotely from the comfort of their own homes, where all investigational products will be delivered, and from where all data collection will occur. The M2S Hot Flash Study is designed to include peri-menopausal and post-menopausal women over the age of 45 who experience at least 7 to 8 moderate to severe hot flashes per day. The three-week trial is being made available to eligible participants nationwide. Participants will be asked to track their vasomotor symptoms online during the trial and complete a survey at the conclusion of the study. The investigational products to be provided include an orally dosed, non-hormonal, non-herbal, non-antidepressant formulation of a compound that has known mechanisms of action, is already widely used for a different indication, and has a long history of safe use. The trial materials will also include training materials to educate participants on how to use the study's patient reporting software. Fervent Pharmaceuticals is a clinical stage drug development company founded in North Carolina in 2011. It is focused on improving women's quality of life by developing therapies targeting unmet needs in women's health. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 5 highly experienced directors. Independent Non-Executive Director Falguni Mehta was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 23
Second quarter 2022 earnings released: EPS ₹0.01 (vs ₹0.009 in 2Q 2021) The company reported a soft second quarter result with weaker earnings and revenues, although profit margins were improved. Second quarter 2022 results: Revenue: ₹2.50m (down 80% from 2Q 2021). Net income: ₹251.0k (down 12% from 2Q 2021). Profit margin: 10.0% (up from 2.3% in 2Q 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 64 percentage points per year, which is a significant difference in performance. Reported Earnings • Jul 14
Full year 2021 earnings released: EPS ₹0.058 (vs ₹0.079 in FY 2020) The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2021 results: Revenue: ₹22.2m (down 70% from FY 2020). Net income: ₹1.75m (down 26% from FY 2020). Profit margin: 7.9% (up from 3.2% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings. Reported Earnings • Jun 20
Full year 2021 earnings released: EPS ₹0.06 (vs ₹0.079 in FY 2020) The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2021 results: Revenue: ₹22.2m (down 70% from FY 2020). Net income: ₹1.75m (down 26% from FY 2020). Profit margin: 7.9% (up from 3.2% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. Reported Earnings • Jan 30
Third quarter 2021 earnings released: EPS ₹0.03 (vs ₹0.03 loss in 3Q 2020) The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₹2.28m (down 96% from 3Q 2020). Net income: ₹753.0k (up ₹1.61m from 3Q 2020). Profit margin: 33% (up from net loss in 3Q 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings. Announcement • Jan 20
Fervent Synergies Limited to Report Q3, 2021 Results on Jan 28, 2021 Fervent Synergies Limited announced that they will report Q3, 2021 results on Jan 28, 2021 Is New 90 Day High Low • Nov 23
New 90-day high: ₹11.52 The company is up 17% from its price of ₹9.88 on 25 August 2020. The Indian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Consumer Finance industry, which is up 21% over the same period. Is New 90 Day High Low • Nov 03
New 90-day low: ₹8.19 The company is down 22% from its price of ₹10.56 on 05 August 2020. The Indian market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Finance industry, which is up 7.0% over the same period. Announcement • Nov 03
Fervent Synergies Limited, Annual General Meeting, Dec 03, 2020 Fervent Synergies Limited, Annual General Meeting, Dec 03, 2020, at 11:00 Indian Standard Time. Reported Earnings • Oct 26
First half earnings released Over the last 12 months the company has reported total losses of ₹71.0k, with earnings decreasing by ₹10.7m from the prior year. Total revenue was ₹84.5m over the last 12 months, down 48% from the prior year. Is New 90 Day High Low • Oct 14
New 90-day low: ₹8.36 The company is down 16% from its price of ₹10.00 on 16 July 2020. The Indian market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Finance industry, which is up 7.0% over the same period. Is New 90 Day High Low • Sep 24
New 90-day low: ₹9.00 The company is down 9.0% from its price of ₹9.92 on 26 June 2020. The Indian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Finance industry, which is up 6.0% over the same period. Announcement • Jul 26
Fervent Synergies Limited to Report Q1, 2021 Results on Jul 30, 2020 Fervent Synergies Limited announced that they will report Q1, 2021 results on Jul 30, 2020 